Related Experiment Video
Updated: Jun 28, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Additional visit burden for universal influenza vaccination of US school-aged children and adolescents
Cynthia M Rand1, Peter G Szilagyi, Byung-Kwang Yoo
1Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. cynthia_rand@urmc.rochester.edu
Insights
Universal influenza vaccination for US children requires millions of extra primary care visits. Even utilizing all existing appointments, most young patients need additional visits for flu shots, highlighting the need for efficient vaccination strategies.
Area of Science:
- Pediatrics
- Public Health
- Epidemiology
Background:
- Influenza vaccination is crucial for child and adolescent health.
- Primary care settings are a key venue for childhood immunizations.
- Estimating the impact of universal vaccination on primary care resources is essential.
Purpose of the Study:
- To determine the number of additional primary care visits required for universal influenza vaccination of US children and adolescents.
- To assess the feasibility of administering all influenza vaccinations within primary care settings.
Main Methods:
- Cross-sectional study utilizing data from the 2003-2004 Medical Expenditure Panel Survey.
- Analysis focused on children aged 5 to 18 years with a usual source of care.
- Calculated the percentage of children needing additional visits based on different vaccination windows (3-, 4-, or 5-month periods).
Main Results:
- A significant majority of children aged 5-18 would require 1-2 additional primary care visits for influenza vaccination.
- Even when utilizing all available visits, substantial numbers of children would need extra appointments.
- Nationally, an estimated 42 million additional visits could be necessary within a 5-month vaccination window.
Conclusions:
- Universal influenza vaccination in primary care settings necessitates a considerable increase in patient visits.
- Current primary care visit structures may be insufficient to accommodate universal influenza vaccination for all children and adolescents.
- Development of efficient vaccination strategies is imperative for primary care practices to achieve universal influenza immunization goals.
Objective:
To estimate the additional primary care visits needed for universal influenza vaccination of all US children and adolescents if all vaccinations occurred in primary care settings.
Design:
Cross-sectional design.
Setting:
Well-child care and other visits to primary care practices from the 2003-2004 Medical Expenditure Panel Survey.
Participants:
Children aged 5 to 18 years (n = 3047) with a usual source of care. Main Outcome Measure Percentage of children needing 0, 1, or 2 additional visits to be immunized against influenza in a 3-, 4-, or 5-month vaccination window.
Results:
In a 3-month window, if only well-child care visits were used for first immunization, 97% of 5- and 6-year-olds and 98% of 7- and 8-year-olds would need 1 or 2 additional visits for complete vaccination; 95% of 9- to 18-year-olds would need 1 visit. If instead all visits were used for immunization, 90% of 5- and 6-year-olds and 91% of 7- and 8-year-olds would need 1 or 2 visits; 78% of 9- to 18-year-olds would need 1 visit. Expanding the window to 4 or 5 months slightly reduces the need for additional visits. Nationally, using all opportunities for vaccination, 42 million additional visits would be needed in a generous 5-month window.
Conclusions:
Most children and adolescents would need additional visits for universal influenza vaccination, even if all existing visits were used as vaccination opportunities. Efficient methods for vaccinating large numbers of children and adolescents are needed if primary care practices are to provide influenza vaccine for all children.
Related Concept Videos
Vaccinations
Influenza
Smallpox
Infectious Diseases and Their Occurrence
Drug Dosing: Infants and Children
Respiratory Syncytial Virus Disease

